X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/717290/Core-One-Labs-Signs-Letter-of-Intent-with-GMP-Manufacturing-Partner-for-Production-of-Proprietary-Psychedelic-Compounds
https://www.accesswire.com/716358/Core-One-Labs-Akome-Move-Psychedelic-Drug-Formulations-to-Next-Stage-of-Development-Initiating-Phase-2-Analysis-of-Therapeutic-Potential
https://www.accesswire.com/711998/Core-One-Labs-Subsidiaries-Successfully-Produce-Psilocin-Precursor-for-Production-to-Psilocybin
https://www.globenewswire.com/news-release/2022/04/06/2417600/0/en/Core-One-Labs-Upgrades-to-OTCQB-Venture-Market.html
https://www.globenewswire.com/news-release/2022/04/02/2415161/0/en/Core-One-Labs-Akome-Receives-Positive-Results-from-Bioassay-Studies.html
https://www.globenewswire.com/news-release/2022/03/19/2406329/0/en/Core-One-Labs-to-Investigate-Soliciting-Investment-and-Potential-Takeover-Opportunities.html
https://www.globenewswire.com/news-release/2022/03/15/2403065/0/en/Core-One-s-Vocan-Biotechnologies-and-Awakened-Biosciences-Collaborate-to-Advance-Vocan-s-Mass-Production-Capabilities.html
https://www.globenewswire.com/news-release/2022/03/13/2402155/0/en/Core-One-Labs-Proceeds-with-Next-Milestone-Achievement-To-Produce-Psilocybin.html
https://www.globenewswire.com/news-release/2022/03/03/2395910/0/en/Core-One-Labs-Announces-Successful-Proof-of-Concept-for-Biosynthetic-N-methyltryptamine-NMT.html
Market Place
Share 
